We’re CLEAR Foundation, or Canadians for Leading Edge Alzheimer Research Foundation, because that’s exactly what we are. We’re on a mission to eradicate all forms of dementia, including Alzheimer disease.
A tidal wave of dementia diagnoses is on the horizon, and the best way to spare future generations the devastation of this disease is to get rid of it once and for all. And the only way to do that is through research. CLEAR is the only Canadian foundation that directs 100% of funds raised to promising scientific research into the cause, prevention, and treatment of Alzheimer Disease and other dementias.
The research we fund with Michael Smith Health Research BC could lead to the breakthrough the world has been waiting for, here in Canada or somewhere else in the world. In the global fight against this unforgiving disease, we’re all in this together.
Note: CLEAR Foundation was formerly known as the Pacific Alzheimer Research Foundation (PARF).
Funding interests
Award types
Scholar, Research Trainee
Research interests
CLEAR (Canadians for Leading edge Alzheimer Research) Foundation is interested in supporting biomedical (and clinical) research to increase understanding of the evolution of Alzheimer disease and related dementias (ADRD) enabling discovery of disease mitigating treatment and one day a cure.
- Alzheimer and related disorders (ADRD)
- neurodegeneration
- Alzheimer prevention
- Alzheimer cause
- Alzheimer treatment
- Alzheimer cure
Awards
2023
Recipient
Amanda OrrAward type
Research trainee award
Project title
3D bioprinting patient-derived neural tissues for screening potential treatments for
Alzheimer’s disease
Recipient
Manu MadhavAward type
Scholar award
Project title
Quantifying navigational impairments in preclinical Alzheimer’s disease
2022
Recipient
Jordan HamdenAward type
Research Trainee award
Project title
In vitro diagnostics for frontotemporal dementia
Recipient
Michael AdachiAward type
Scholar award
Project title
Developing sensors for rapid detection of biomarker proteins for Alzheimer’s disease
2020
Recipient
Narlon Boa Sorte SilvaAward type
Research Trainee award
Project title
Resisting Vascular Cognitive Impairment: The Effects of Resistance Training on Myelin and Blood-based Biomarkers of Neuroplasticity in Older Adults
Recipient
Katherine ElviraAward type
Scholar award
Project title
Building bespoke artificial cells and tissues on a chip for drug discovery
2017
Recipient
Dustin KingAward type
Research Trainee award
Project title
Elucidating the effect of O-GlcNAc modification on protein stability
2016
Recipient
Arya MehranAward type
Research Trainee award
Project title
Neurally-produced estradiol enhances the neuroprotective actions of insulin
Recipient
Haakon NygaardAward type
Scholar award
Project title
Chemical suppression of nonsense mutations for the treatment of Frontotemporal Dementia
2015
Recipient
Vedrana CvetkovskaAward type
Research Trainee Award
Project title
The mechanism and significance of the synaptogenic activity of amyloid precursor protein
Recipient
Jasmin HefendehlAward type
Research Trainee Award
Project title
Altered glutamate dynamics in a mouse model of Alzheimer’s disease: Novel early biomarkers with therapeutic potential
Recipient
Yun ZhangAward type
Research Trainee Award
Project title
Human islet amyloid polypeptide aggregation, the missing link between type 2 diabetes and Alzheimer’s disease?
Recipient
Sieun LeeAward type
Research Trainee Award
Project title
Are there indicators of Alzheimer’s disease in the eye?: New computational imaging and analysis algorithms
Recipient
David VocadloAward type
British Columbia Alzheimer’s Research Award
Project title
Preclinical development of a disease modifying small molecule therapy for Alzheimer disease
Recipient
James JohnsonAward type
British Columbia Alzheimer’s Research Award
Project title
Locally produced brain insulin in memory and Alzheimer’s disease: A multi-disciplinary approach to a key question
Recipient
Christian NausAward type
British Columbia Alzheimer’s Research Award
Project title
Validation of connexins and pannexins as a target for Alzheimer’s disease
Recipient
Faisal BegAward type
British Columbia Alzheimer’s Research Award
Project title
Novel retinal biomarkers for Alzheimer’s disease
2013
Recipient
Neil CashmanAward type
British Columbia Alzheimer’s Research Award
Project title
Targeting amyloid propagation in Alzheimer disease: Structures, immunology and extracellular vesicle topology